NCT01576705View on ClinicalTrials.gov

Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children

PHASE3CompletedINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

April 2, 2012

Primary Completion Date

December 14, 2017

Study Completion Date

December 14, 2017

Conditions

Down Syndrome

Interventions

DRUG

thyroid hormone and folinic acid

thyroid hormone 25microg or placebo in tablets folinic acid 5 mg or placebo in capsules

Trial Locations (1)

75015

Institut Jerome Lejeune, Paris

All Listed Sponsors

collaborator

Hôpital Cochin

OTHER

collaborator

Central Hospital, Nancy, France

OTHER

lead

Institut Jerome Lejeune

OTHER

NCT01576705 - Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children | Biotech Hunter | Biotech Hunter